Aroa Biosurgery Limited
AROAF
$0.35
$0.000.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 13.48% | 19.70% | 24.16% | 20.21% | 6.35% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 13.48% | 19.70% | 24.16% | 20.21% | 6.35% |
| Cost of Revenue | 27.29% | 34.27% | 3.30% | 0.01% | -5.31% |
| Gross Profit | 11.32% | 17.42% | 28.10% | 24.03% | 8.45% |
| SG&A Expenses | -9.69% | -4.73% | 21.58% | 17.72% | 21.09% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 34.40% | 30.82% | 38.31% | 40.28% | 31.19% |
| Total Operating Expenses | -4.32% | 0.93% | 18.58% | 14.81% | 14.14% |
| Operating Income | 137.41% | 139.47% | 12.62% | 15.40% | -152.27% |
| Income Before Tax | 92.50% | 92.08% | 52.38% | 53.90% | -100.12% |
| Income Tax Expenses | 168.48% | 183.98% | 178.45% | 169.95% | 165.71% |
| Earnings from Continuing Operations | 88.87% | 88.26% | 47.21% | 48.89% | -112.05% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 88.87% | 88.26% | 47.21% | 48.89% | -112.05% |
| EBIT | 137.41% | 139.47% | 12.62% | 15.40% | -152.27% |
| EBITDA | 198.97% | 205.88% | 17.54% | 20.16% | -835.39% |
| EPS Basic | 89.47% | 89.47% | 48.21% | 49.12% | -111.11% |
| Normalized Basic EPS | 91.67% | 91.30% | 52.94% | 54.29% | -100.00% |
| EPS Diluted | 89.47% | 89.47% | 48.21% | 49.12% | -111.11% |
| Normalized Diluted EPS | 91.67% | 91.30% | 52.94% | 54.29% | -100.00% |
| Average Basic Shares Outstanding | 0.25% | 0.25% | 0.37% | 0.37% | 0.40% |
| Average Diluted Shares Outstanding | 0.25% | 0.25% | 0.37% | 0.37% | 0.40% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |